Health Professional Radio - Podcast

Returning guest, Dr. William Sandborn, MD, Chief of Gastroenterology, Professor of Medicine, University of California, San Diego, discusses positive study results in Crohn's disease from the IM-UNITI trial on STELARA'S efficacy at five years and the TREMFYA GALAXI-1 trial, Phase 2, week 12 Interim Analyses Data. The GALAXI abstract has been recognized among the three highest scoring UEGW (United European Gastroenterology Week) 2020 abstracts in one of the main categories.